AG
AMPH icon

Aperio Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Aperio Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$557K Buy
27,684
+2,768
+11% +$53.9K ﹤0.01% 1915
2020
Q3 		$467K Buy
24,916
+911
+4% +$18.3K ﹤0.01% 1846
2020
Q2 		$539K Sell
24,005
-9,652
-29% -$177K ﹤0.01% 1736
2020
Q1 		$500K Buy
33,657
+14,044
+72% +$244K ﹤0.01% 1649
2019
Q4 		$378K Sell
19,613
-8,070
-29% -$155K ﹤0.01% 1954
2019
Q3 		$549K Sell
27,683
-2,318
-8% -$48.3K ﹤0.01% 1707
2019
Q2 		$633K Sell
30,001
-3,736
-11% -$78.1K ﹤0.01% 1648
2019
Q1 		$689K Buy
33,737
+6,466
+24% +$145K ﹤0.01% 1561
2018
Q4 		$543K Buy
27,271
+6,600
+32% +$130K ﹤0.01% 1629
2018
Q3 		$398K Buy
20,671
+2,856
+16% +$50.9K ﹤0.01% 1891
2018
Q2 		$272K Buy
17,815
+2,702
+18% +$47.2K ﹤0.01% 2037
2018
Q1 		$283K Buy
15,113
+109
+0.7% +$2.05K ﹤0.01% 1979
2017
Q4 		$289K Buy
15,004
+1,334
+10% +$24.9K ﹤0.01% 1956
2017
Q3 		$245K Buy
13,670
+789
+6% +$13K ﹤0.01% 2033
2017
Q2 		$231K Sell
12,881
-443
-3% -$7.03K ﹤0.01% 2034
2017
Q1 		$193K Buy
+13,324
New +$210K ﹤0.01% 2043

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aperio Group's AMPH Position: Q4 2020 in Review

Aperio Group increased its Amphastar Pharmaceuticals (AMPH) stake by 11% in Q4 2020, buying an estimated $53.9K and bringing the position to 27,684 shares worth $557K. The position accounts for ﹤0.01% of the portfolio, ranked #1915.

Aperio Group first reported a position in AMPH in Q1 2017 and has held it in 16 quarters since. The position peaked at $689K in Q1 2019. 129 funds tracked by Wall St. Rank hold AMPH as of Q4 2020.

  • Aperio Group held 27,684 shares of Amphastar Pharmaceuticals worth $557K as of Q4 2020.
  • Aperio Group bought 2,768 Amphastar Pharmaceuticals shares in Q4 2020, an estimated $53.9K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1915 holding.
  • Aperio Group first reported a position in Amphastar Pharmaceuticals in Q1 2017 and has held it in 16 quarters since.
  • Aperio Group's Amphastar Pharmaceuticals position peaked at $689K in Q1 2019.
  • 129 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.